Mirum Pharmaceuticals
MIRM
80.64
+1.39
+1.75%
Mirum Pharmaceuticals
US · MIRM
#2051 by market cap
Listed 2019
80.64
+1.39
+1.75%
Live - 5344 symbols - heartbeat 430s ago
· 2026-10-07 19:54
After-hours
80.64
0.00%
- Market cap
- 5.24B
- P/E (TTM)i
- -5.73
- P/Bi
- -500.87
- EPSi
- -0.47
- Div yieldi
- 0.00%
- 52W posi
- 26%
Reader sentiment
Are you bullish or bearish on MIRM?
Anonymous reader poll. Unscientific, not investment advice.
About Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
- Founded
- 2018
- CEO
- Mr. Christopher Peetz
- Employees
- 372
- Headquarters
- Foster City, California, United States of America
- Fiscal year end
- 12-31
- Website
- mirumpharma.com
Company profile
- Exchange
- US
- Symbol
- MIRM
- Market-cap rank
- #2051
- Listing date
- 2019-07-18
- Market cap
- 5.24B
- Float cap
- 4.55B
- Shares out
- 64.93M
- Float shares
- 56.41M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.